These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 8132322

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess.
    Lotter H, Rüssmann H, Heesemann J, Tannich E.
    Infect Immun; 2004 Dec; 72(12):7318-21. PubMed ID: 15557659
    [Abstract] [Full Text] [Related]

  • 25. Development of amebicidal cell-mediated immunity in gerbils (Meriones unguiculatus) immunized with the galactose-inhibitable adherence lectin of Entamoeba histolytica.
    Schain DC, Salata RA, Ravdin JI.
    J Parasitol; 1995 Aug; 81(4):563-8. PubMed ID: 7623198
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.
    Ivory CP, Keller K, Chadee K.
    Infect Immun; 2006 Jan; 74(1):528-36. PubMed ID: 16369009
    [Abstract] [Full Text] [Related]

  • 29. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI, Shain DC, Kelsall BL.
    Vaccine; 1993 Jan; 11(2):241-6. PubMed ID: 8438621
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD, Petri WA.
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by Entamoeba histolytica protects gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver.
    Giménez-Scherer JA, Cárdenas G, López-Osuna M, Velázquez JR, Rico G, Isibasi A, Maldonado Mdel C, Morales ME, Fernández-Diez J, Kretschmer RR.
    Parasite Immunol; 2004 Sep; 26(8-9):343-9. PubMed ID: 15679631
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. An Entamoeba histolytica antigen devoid of enzymatic activity, but endowed with immunogenic and protective properties.
    Portnoy L, Oliva A, Antonio-Ramírez J, Castellanos C, del Muro R, Ortíz-Ortíz L.
    Arch Invest Med (Mex); 1990 Sep; 21 Suppl 1():27-34. PubMed ID: 2136496
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The EhADH112 recombinant polypeptide inhibits cell destruction and liver abscess formation by Entamoeba histolytica trophozoites.
    Martínez-López C, Orozco E, Sánchez T, García-Pérez RM, Hernández-Hernández F, Rodríguez MA.
    Cell Microbiol; 2004 Apr; 6(4):367-76. PubMed ID: 15009028
    [Abstract] [Full Text] [Related]

  • 40. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.
    Marinets A, Zhang T, Guillén N, Gounon P, Bohle B, Vollmann U, Scheiner O, Wiedermann G, Stanley SL, Duchêne M.
    J Exp Med; 1997 Nov 03; 186(9):1557-65. PubMed ID: 9348313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.